Yiwei Zhang

Yiwei Zhang serves as Senior Director of Biostatistics at Apellis Pharmaceuticals since August 2021, leading the portfolio for systemic therapeutics across hematology, nephrology, and neurology, while managing a team to support clinical development and medical affairs. Previously, roles included Associate Director at Biogen, focusing on study design for a pivotal Lupus program, and Associate Director of Biostatistics at bluebird bio, where contributions included pivotal studies and EMA filing. With a strong foundation in biostatistics, experience spans positions at Biogen, Novartis, and academic roles at the University of Minnesota, enhanced by a PhD in Biostatistics and an MS in Statistics.